The goal of Medsider is simple: Help ambitious doers and thinkers learn from experienced medtech thought leaders.
Most of the time, this is accomplished through uncut and unedited interviews with medtech stakeholders. These proven experts will show you how to:
Effectively market medical devices.
Obtain investor funding.
Enhance your regulatory approval procedures.
Strengthen your reimbursement strategies.
And much, much more!
Sound appealing? Just enter your email address below to receive free Medsider updates.
Who is Scott Nelson?
Scott Nelson is a medtech enthusiast, ambitious doer, and intellectually curious. He founded Medsider in 2010 with one simple goal: Help ambitious doers learn from experienced medtech thought leaders. His work with Medsider has been featured in publications like Forbes, Mass Device, MedCity News, and MD+DI.
Scott has held sales and marketing leadership positions for some of the largest medical device companies in the world including Medtronic, Covidien, Boston Scientific, C.R. Bard, and ConMed. He currently leads partnerships for Touch Surgery and also serves as an advisor to Metric6 as well as the Medical Devices Group, which includes over 300,000 members worldwide. He holds a BA in Biology from Grand View University. Scott is best friends with his wife, Liz, and they are committed parents to their 4 beautiful children – Elliana, Madalyn, Leland, and Oliver. Connect with Scott via LinkedIn or Twitter.
Here are some of the sites Scott has either been quoted or featured in:
Would you like to follow Scott’s work with Medsider? Just enter your email address below to receive free Medsider updates.
What Other People Say About Scott
Scott has a combination of skill sets that is highly desirable and very difficult to find.”
Scott is a forward-thinking innovator and a leader in every sense of the word.”
Scott is not only very sharp, but he is entrepreneurial at a time when medical device marketing and sales efforts must be flexible and adaptive to the changing environment. I cannot think of anyone who is better suited for the current medtech climate.”
Would you like to learn from experienced medtech thought leaders? Just enter your email address below to receive free Medsider updates.